Skip to main content

Lucid Diagnostics Inc 10-Q for FY2026 Q3

Lucid Diagnostics Inc. (LUCD)

10-Q 2026-11-12 For: 2026-09-30
View Original
Added on November 12, 2026

About this 10-Q

Lucid Diagnostics Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Lucid Diagnostics Inc. reported a $45.0 million net loss attributable to common stockholders for nine months ended September 30, 2026, raising substantial doubt about continuing as a going concern. A subsequent Series C preferred stock sale raised approximately $15.0 million. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.2M
down 0.7% from $1.21M a year earlier
Net loss
$6.68M
compared with a net loss of $10.4M a year earlier